Read our bumper June 2018 issue

Introducing our June issue, we include a range of company profiles and feature articles focused on infectious diseases, IP protection and fibrosis.

Like Comment

Our biggest issue of the year is here. Features and company profiles included cover infectious diseases, life science IP protection and fibrosis.

Features include - 

  • Exploring the infectious disease landscape
  • How to protect your intellectual life science IP
  • Focus on fibrosis

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.